Anti-inflammatory Cannula Coating for Extended Wear
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Cannulas used for long-term medication delivery often cause inflammation, infection, or thrombus formation due to bacterial presence and unintended blood flow, leading to patient discomfort and reduced therapy effectiveness.
Innovation Solution
A cannula coated or compounded with hydrophilic, anti-microbial, anti-inflammatory, or anti-thrombogenic materials, such as polymers or metallic coatings, to extend wear time and reduce physiological changes at the insertion site, including materials like heparin, silver, and fluoropolymers, applied through methods like vapor deposition or co-extrusion.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of moving object
If a cannula is used for long-term medication delivery, then therapy effectiveness is improved, but inflammation and infection occur at the insertion site
Solution Approach 1:
A coating layer is applied to the cannula surface that acts as an intermediary between the cannula and the patient's tissue. This coating contains anti-inflammatory and anti-microbial agents that are released over time to prevent inflammation and infection, allowing the cannula to remain in place longer without causing adverse reactions.
Solution Approach 2:
The chemical composition of the cannula surface is changed by applying a coating with different material properties. The coating has anti-inflammatory and anti-microbial characteristics that modify the interaction between the cannula and biological tissue, reducing harmful effects while maintaining insertion duration.
2Duration of action of stationary object
If a cannula remains in place for extended periods, then long-term therapy is achieved, but thrombus formation occurs
Solution Approach 1:
The coating layer serves as a mediator that prevents direct contact between the cannula surface and blood components. Anti-thrombogenic agents in the coating reduce blood adhesion and prevent clot formation on the cannula surface during extended insertion periods.
Solution Approach 2:
The coating acts as a sacrificial layer that degrades or depletes over time, providing continuous protection against thrombus formation. Once the coating's active agents are exhausted, the cannula is removed, replacing the protective layer rather than the entire device.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The coated cannula reduces inflammation and extends the duration of cannula insertion, enhancing the effectiveness of drug delivery and patient comfort by minimizing adverse physiological responses.
Implementation Method 1
A cannula coated or compounded with hydrophilic, anti-microbial, anti-inflammatory, or anti-thrombogenic materials
Implementation Method 2
A cannula coated or compounded with hydrophilic, anti-microbial, anti-inflammatory, or anti-thrombogenic materials
Implementation Method 3
A cannula coated or compounded with hydrophilic, anti-microbial, anti-inflammatory, or anti-thrombogenic materials
Implementation Method 4
A cannula coated or compounded with hydrophilic, anti-microbial, anti-inflammatory, or anti-thrombogenic materials
Data Source
AI summary
Various embodiments of the present invention include a cannula coated or compounded with a material to extend the wear time for a patient by reducing inflammation and therefore increasing the time that the cannula may remain inserted, thereby increasing the effectiveness of the drug delivered using the cannula. The material may include a hydrophilic material, an anti-microbial material, an anti-inflammatory material, anti-thrombogenic material, or a combination of any of these materials.